Live tape
Top 8, mentions 7d6,223META1,812 mentions▲ +0.06GOOGL1,253 mentions▲ +0.02NVDA720 mentions▲ +0.09MSFT539 mentions▲ +0.06MUSE508 mentions▲ +0.06TSLA481 mentions▲ +0.05SPY476 mentions▲ +0.04QQQ434 mentions▲ +0.07

Equity · Healthcare

EVH

Evolent Health, Inc. · NYSE

$3 −5.36% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 31, 2026
Price · Chart
Our own end-of-day closes 22 sessions
$8 $2 1 Jul 31 Jul

The line runs $5.73 on 1 July through $3 on 31 July, on a scale from $2 to $8. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of EVH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 22 sessions over that window: $5.73 on 1 July 2026 through $3 on 31 July 2026.

Market cap $339.2M
52-week range $2.16 – $10.06
Avg volume 628.2K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 31, 2026

EVH insider trades

SEC Form 4 · last 90 days · newest reported trade 26 Aug 2026
Open-market buys 0
Open-market sells 1
Net sold $329K
Non-trade filings 7
Date Insider Type Shares Value
26 Aug 2026 McCarthy Daniel Joseph PRESIDENT Sell 65,892 $329K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Jul 2026 Blackley Seth Chief Executive Officer Award 446,102
01 Jul 2026 Blackley Seth Chief Executive Officer Tax withheld 10,297 $59K
01 Jul 2026 Shams Aammaad Chief Accounting Officer Award 28,790
01 Jul 2026 McCarthy Daniel Joseph PRESIDENT Award 302,585
01 Jul 2026 McCarthy Daniel Joseph PRESIDENT Tax withheld 4,582 $26K
01 Jul 2026 Weinberg Jonathan General Counsel Award 43,055
01 Jul 2026 Weinberg Jonathan General Counsel Tax withheld 2,650 $15K

EVH reported financials

SEC EDGAR XBRL

EVH reported revenue of $1.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$534.5M.

Figure Reported Period
Revenue $1.9B 31 Dec 2025 fiscal year
Net income −$534.5M 31 Dec 2025 fiscal year
Diluted EPS −$5.07 31 Dec 2025 fiscal year
Total assets $2.0B 30 Jun 2026 at period end
Total equity $383.2M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

EVH earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.25 —
31 Mar 2026 Q1 2026 $-0.24 —
31 Dec 2025 FY 2025 $-3.84 —
30 Sep 2025 FY 2025 $-0.24 —
30 Jun 2025 FY 2025 $-0.44 —
31 Mar 2025 Q1 2025 $-0.63 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

EVH institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a EVH position for the quarter ended 30 Jun 2026 — a combined $69.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) −6.0% shares 5,107,561 $27.7M
Marshall Wace Added +334.8% shares 3,413,245 $18.5M
Two Sigma Investments Added +45.0% shares 1,263,653 $6.8M
AQR Capital Management Added +355.6% shares 792,768 $4.3M
Tudor Investment Corp Added +579.8% shares 699,267 $3.8M
Man Group Added +414.3% shares 498,272 $2.7M
Citadel Advisors Trimmed −30.7% shares 488,814 $2.6M
Millennium Management Held (±25%) −19.3% shares 303,343 $1.6M
GAMCO Investors Held (±25%) −14.5% shares 247,500 $1.3M
Balyasny Asset Management Trimmed −92.0% shares 30,523 $165K

Source: SEC EDGAR 13F filings

EVH fails-to-deliver

SEC CNS data

On 27 Aug 2026, 352 shares of EVH failed to deliver (about $2K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
27 Aug 2026 352 $2K <0.001%
26 Aug 2026 226,796 $1.1M 0.201%

Source: SEC fails-to-deliver (CNS) data